ImExHS Ltd

As of December 31, 2025, ImExHS Ltd carries a market capitalization of 21.62M, placing it among publicly traded companies globally. Its enterprise value stands at 18.89M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

ImExHS Ltd's next confirmed earnings release is scheduled for March 1, 2027.

As of December 31, 2025, ImExHS Ltd has 54.05M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 0.71, and the price-to-book ratio stands at 1.36.

These figures are as of December 31, 2025. The EV/Sales ratio of 0.65 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 18.89M versus a market cap of 21.62M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, ImExHS Ltd maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.57, indicating elevated leverage, while an interest coverage ratio of -1.18 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, ImExHS Ltd posted a negative return on equity (ROE) of -19.00, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -12.66, reflecting losses generated across the asset base. The company generates approximately 99,896.75 in revenue per employee across its workforce of 290.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended December 31, 2025, ImExHS Ltd recorded an income tax benefit of -156,602.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -3.04M and -2.88M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 20, 2026, ImExHS Ltd's stock has gained approximately 30.61% over the past 52 weeks. The 50-day moving average sits at 0.32, while the 200-day moving average is 0.32.

Over the twelve months ended December 31, 2025, ImExHS Ltd generated 28.97M in revenue and converted that into -2.88M in net income, yielding earnings per share of -0.06. EBITDA reached -433,681.00, while operating income came in at -897,194.00.

As of December 31, 2025, ImExHS Ltd holds 3.30M in cash and equivalents against 566,323.00 in total debt, resulting in a net debt position of -2.77M. Total book value stands at 15.87M, with working capital of 5.68M providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

These figures cover the twelve months ended December 31, 2025. The operating margin of -3.10 and net profit margin of -9.95 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield is negative at -7.76, meaning ImExHS Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

ImExHS Ltd's most recent stock split took place on August 5, 2022 with a 904:909 split ratio.

As of December 31, 2025, ImExHS Ltd has an Altman Z-Score of 0.85, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.